Fully Supramolecular Polyrotaxanes as Biphase Drug Delivery Systems

Pseudopolyrotaxanes (PPR) consisting of α-cyclodextrin rings and polyethylene glycol axes with end thymine groups have been synthesized and characterized successfully. Fluorescein (Fl) as a model drug was conjugated to the hydroxyl functional groups of cyclodextrin rings of PPR via ester bonds and P...

Full description

Bibliographic Details
Main Authors: Abdolhossien Massoudi, Mohsen Adeli, Leila Khosravi far
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:International Journal of Polymer Science
Online Access:http://dx.doi.org/10.1155/2014/829474
id doaj-f88c6af9119d41c2a159f3a4ac624d41
record_format Article
spelling doaj-f88c6af9119d41c2a159f3a4ac624d412020-11-24T21:20:52ZengHindawi LimitedInternational Journal of Polymer Science1687-94221687-94302014-01-01201410.1155/2014/829474829474Fully Supramolecular Polyrotaxanes as Biphase Drug Delivery SystemsAbdolhossien Massoudi0Mohsen Adeli1Leila Khosravi far2Department of Chemistry, Payame Noor University, Tehran 19395-4697, IranDepartment of Chemistry, Lorestan University, Khoramabad, IranDepartment of Chemistry, Payame Noor University, Tehran 19395-4697, IranPseudopolyrotaxanes (PPR) consisting of α-cyclodextrin rings and polyethylene glycol axes with end thymine groups have been synthesized and characterized successfully. Fluorescein (Fl) as a model drug was conjugated to the hydroxyl functional groups of cyclodextrin rings of PPR via ester bonds and PPR-Fl as the primary drug delivery system was obtained. Finally PPR-Fl was capped by hydrogen bonds between end thymine groups and a suitable complementary molecule such as polycitric acid, citric acid, or adenine. The aim of this work was to control the release of the fluorescein-cyclodextrin (Fl-CD) conjugates, as the secondary drug delivery systems, from PPR-Fl by controlling the noncovalent interactions between stoppers and thymine end groups. It was found that the rate of release of the Fl-CD from PPR-Fl could be controlled by pH and the ratio of citric acid or adenine to the PPR-Fl.http://dx.doi.org/10.1155/2014/829474
collection DOAJ
language English
format Article
sources DOAJ
author Abdolhossien Massoudi
Mohsen Adeli
Leila Khosravi far
spellingShingle Abdolhossien Massoudi
Mohsen Adeli
Leila Khosravi far
Fully Supramolecular Polyrotaxanes as Biphase Drug Delivery Systems
International Journal of Polymer Science
author_facet Abdolhossien Massoudi
Mohsen Adeli
Leila Khosravi far
author_sort Abdolhossien Massoudi
title Fully Supramolecular Polyrotaxanes as Biphase Drug Delivery Systems
title_short Fully Supramolecular Polyrotaxanes as Biphase Drug Delivery Systems
title_full Fully Supramolecular Polyrotaxanes as Biphase Drug Delivery Systems
title_fullStr Fully Supramolecular Polyrotaxanes as Biphase Drug Delivery Systems
title_full_unstemmed Fully Supramolecular Polyrotaxanes as Biphase Drug Delivery Systems
title_sort fully supramolecular polyrotaxanes as biphase drug delivery systems
publisher Hindawi Limited
series International Journal of Polymer Science
issn 1687-9422
1687-9430
publishDate 2014-01-01
description Pseudopolyrotaxanes (PPR) consisting of α-cyclodextrin rings and polyethylene glycol axes with end thymine groups have been synthesized and characterized successfully. Fluorescein (Fl) as a model drug was conjugated to the hydroxyl functional groups of cyclodextrin rings of PPR via ester bonds and PPR-Fl as the primary drug delivery system was obtained. Finally PPR-Fl was capped by hydrogen bonds between end thymine groups and a suitable complementary molecule such as polycitric acid, citric acid, or adenine. The aim of this work was to control the release of the fluorescein-cyclodextrin (Fl-CD) conjugates, as the secondary drug delivery systems, from PPR-Fl by controlling the noncovalent interactions between stoppers and thymine end groups. It was found that the rate of release of the Fl-CD from PPR-Fl could be controlled by pH and the ratio of citric acid or adenine to the PPR-Fl.
url http://dx.doi.org/10.1155/2014/829474
work_keys_str_mv AT abdolhossienmassoudi fullysupramolecularpolyrotaxanesasbiphasedrugdeliverysystems
AT mohsenadeli fullysupramolecularpolyrotaxanesasbiphasedrugdeliverysystems
AT leilakhosravifar fullysupramolecularpolyrotaxanesasbiphasedrugdeliverysystems
_version_ 1726002449006723072